India Business Law Journal Names Cravath Among Top Players of 2023 for India‑Related Work
August 15, 2023
On August 14, 2023, the India Business Law Journal named Cravath among the “Significant Players” in its 2023 ranking of the top international law firms for India‑related work. The publication noted the Firm’s work to help “Indian companies navigate US‑related capital raising transactions, M&A, joint ventures, disputes, and related compliance and reporting advice,” and highlighted its representation of Viatris in its acquisitions of Oyster Point and Famy Life Sciences to create an ophthalmology franchise. The Firm was also recognized for its representation of Airspan in its sale of Mimosa to Radisys on a debt‑free, cash‑free basis.
Related Practices & Industries
Related News
Deals & Cases
November 07, 2022
Viatris’ Acquisitions of Oyster Point and Famy Life Sciences
On November 7, 2022, Viatris Inc. (“Viatris”), a global healthcare company, announced it intends to create an ophthalmology franchise by acquiring Oyster Point Pharma (“Oyster Point”) and Famy Life Sciences.
Deals & Cases
March 09, 2023
Airspan’s Sale of Mimosa to Radisys
On March 8, 2023, Airspan Networks Holdings (“Airspan”), a provider of software and hardware for 5G networks and a pioneer in end‑to‑end Open RAN solutions that provide interoperability with other vendors, announced the signing of definitive agreements for the sale of Mimosa Networks, Inc. (“Mimosa”) to Radisys Corporation (“Radisys”), a wholly owned subsidiary of Jio Platforms Limited, which is a subsidiary of Reliance Industries Limited, on a debt free, cash free basis. Cravath is representing Airspan in connection with the transaction.
